Skip to main content

Pharmaceuticals

Enabling quick and smart access to Pharmaceuticals ingredients, we bring API expertise with a worldwide sourcing, and have a certified Excipients experience. Either you are looking for Veterinary API’s, Human API’s, Excipients, API Impurities, you can find them quickly by browsing our online catalog.

Pharmaceuticals

11 results for Pharmaceuticals
CLEAR ALL
Livzon
Veterinary API designed for pharmaceutical formulations. Benefits:
  • Complies with CVP, USP and EP
  • USFDA approved
  • Meets with CEP and GMP regulations
Livzon
Veterinary API developed for pharmaceutical formulations. Benefits:
  • Complies with USP and EP
  • USFDA approved
  • Meets with CEP and GMP regulations
Jiangxi Tianxin
API designed for use in pharmaceutical applications.Benefits:
  • Complies with the specifications of EP10
CEP available 
Jiangxi Tianxin
API suitable for pharmaceutical preparations.Benefits:
  • Complies with the specifications of EP10
CEP available 
Shandong Xinhua Pharmaceuticals
API for use in pharmaceutical applications. Benefits: 
  • Meets with the requirements of Ph Eur 9.0 and R1-CEP 2001-210-Rev05
Shandong Xinhua Pharmaceuticals
API used for pharmaceutical applications. Benefits: 
  • Meets with the requirements of Ph Eur 9.0 and R1-CEP 2001-210-Rev05
Shandong Xinhua Pharmaceuticals
API designed for use in pharmaceutical preparations.Benefits: 
  • Meet with the specifications of EP10
Shandong Xinhua Pharmaceuticals
API for use in pharmaceutical applications. Benefits: 
  • Meets with the specifications of EP9.0 and R1-CEP2001-356-Rev04 
Shandong Xinhua Pharmaceuticals
API for use in pharmaceutical applications. Benefits: 
  • Meets with the specifications of Ph Eur 10.0 and R1-CEP2002-093-Rev03 
Shandong Xinhua Pharmaceuticals
API for use in pharmaceutical applications. Benefits: 
  • Meets with the specifications of Bayer (France) standard and R1-CEP 2003-059-Rev04 
Shandong Xinhua Pharmaceuticals
API for use in pharmaceutical products. Benefits: 
  • Meets with the specifications of BP 2021, EP 10.0 and R1-CEP 1998-004-Rev07